Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
- Nat Commun. 2025 Nov 13;16(1):9822. doi: 10.1038/s41467-025-65098-z.
- 1. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, VIC, Australia. [email protected].
- 2. Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. [email protected].
- 3. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, VIC, Australia.
- 4. Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.
- 5. College of Life Sciences, Nankai University, Tianjin, China.
- 6. Department of Microbiology and Immunology, the University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
- 7. Section of Anatomic Pathology, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Werribee, Victoria, VIC, Australia.
- 8. Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, VIC, Australia.
- 9. School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, VIC, Australia.
- 10. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, VIC, Australia. [email protected].
- 11. Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. [email protected].
- 12. Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia. [email protected].
- 13. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, VIC, Australia. [email protected].
- 14. Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. [email protected].
Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that Caspase-8 is critical for cytokine release and inflammation. Loss of Caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of Pyroptosis and Necroptosis mediators in gene-targeted Animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of Caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of Caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of Caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of Apoptosis.